In the past week, HUM stock has gone up by 3.51%, with a monthly decline of -14.38% and a quarterly plunge of -30.61%. The volatility ratio for the week is 5.03%, and the volatility levels for the last 30 days are 4.43% for Humana Inc. The simple moving average for the last 20 days is -1.84% for HUM stock, with a simple moving average of -23.45% for the last 200 days.
Is It Worth Investing in Humana Inc. (NYSE: HUM) Right Now?
Humana Inc. (NYSE: HUM) has a higher price-to-earnings ratio of 19.04x compared to its average ratio. HUM has 36-month beta value of 0.49. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 7 as “overweight,” 7 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HUM is 120.10M, and currently, short sellers hold a 2.22% ratio of that float. The average trading volume of HUM on October 21, 2024 was 1.96M shares.
HUM) stock’s latest price update
The stock of Humana Inc. (NYSE: HUM) has increased by 0.30 when compared to last closing price of 266.34. Despite this, the company has experienced a 3.51% gain in its stock price over the last five trading sessions. accesswire.com reported 2024-10-20 that LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Humana Inc. (“Humana” or “the Company”) (NYSE:HUM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Analysts’ Opinion of HUM
Bernstein, on the other hand, stated in their research note that they expect to see HUM reach a price target of $308. The rating they have provided for HUM stocks is “Outperform” according to the report published on October 08th, 2024.
TD Cowen gave a rating of “Hold” to HUM, setting the target price at $261 in the report published on October 07th of the current year.
HUM Trading at -15.41% from the 50-Day Moving Average
After a stumble in the market that brought HUM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.58% of loss for the given period.
Volatility was left at 4.43%, however, over the last 30 days, the volatility rate increased by 5.03%, as shares sank -13.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.74% lower at present.
During the last 5 trading sessions, HUM rose by +3.51%, which changed the moving average for the period of 200-days by -42.49% in comparison to the 20-day moving average, which settled at $272.14. In addition, Humana Inc. saw -41.65% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HUM starting from Mesquita Jorge S., who purchase 545 shares at the price of $367.09 back on Feb 20 ’24. After this action, Mesquita Jorge S. now owns 2,578 shares of Humana Inc., valued at $200,066 using the latest closing price.
Stock Fundamentals for HUM
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.88 for the gross margin
The net margin for Humana Inc. stands at 0.02. The total capital return value is set at 0.1. Equity return is now at value 10.21, with 3.21 for asset returns.
Based on Humana Inc. (HUM), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at -0.33. The debt to equity ratio resting at 0.77. The interest coverage ratio of the stock is 5.26.
Currently, EBITDA for the company is 4.73 billion with net debt to EBITDA at 3.23. When we switch over and look at the enterprise to sales, we see a ratio of 0.35. The receivables turnover for the company is 27.39for trailing twelve months and the total asset turnover is 2.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.66.
Conclusion
To put it simply, Humana Inc. (HUM) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
